This is agood study to explained the mechanism of trastuzumab toxicity.
Competing interests
None declared
use in the clinical
Joon Anderson, Research Institute
17 November 2011
This is a good study, but we need to confirm this result in the clinical trial, because the cardiomyopathy is a real adverse effect of trastuzumab when we used it in the treatmnet of Her2/neu positive breast cancer. Anderson
intersting study!!
17 November 2011
This is agood study to explained the mechanism of trastuzumab toxicity.
Competing interests
None declared
use in the clinical
17 November 2011
This is a good study, but we need to confirm this result in the clinical trial, because the cardiomyopathy is a real adverse effect of trastuzumab when we used it in the treatmnet of Her2/neu positive breast cancer.
Anderson
Competing interests
None declared